These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12613623)

  • 1. Design and synthesis of potent N1-substituted indole melatonin receptor agonists.
    Tsotinis A; Eleutheriades A; Hough K; Sugden D
    Chem Commun (Camb); 2003 Feb; (3):382-3. PubMed ID: 12613623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and melatoninergic activity of new azido- and isothiocyanato-substituted indoles.
    Tsotinis A; Afroudakis PA; Davidson K; Prashar A; Sugden D
    J Med Chem; 2007 Dec; 50(25):6436-40. PubMed ID: 17988084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
    Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
    J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.
    Spadoni G; Balsamini C; Bedini A; Diamantini G; Di Giacomo B; Tontini A; Tarzia G; Mor M; Plazzi PV; Rivara S; Nonno R; Pannacci M; Lucini V; Fraschini F; Stankov BM
    J Med Chem; 1998 Sep; 41(19):3624-34. PubMed ID: 9733487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of N1-phenethyl substituted indole derivatives as new melatoninergic agonists and antagonists.
    Tsotinis A; Vlachou M; Eleutheriades A; Prinea E; Ebreo D; The MT; Sugden D
    Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):31-9. PubMed ID: 11824582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
    Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
    J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
    Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
    J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.
    Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A
    J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.
    Spadoni G; Balsamini C; Diamantini G; Di Giacomo B; Tarzia G; Mor M; Plazzi PV; Rivara S; Lucini V; Nonno R; Pannacci M; Fraschini F; Stankov BM
    J Med Chem; 1997 Jun; 40(13):1990-2002. PubMed ID: 9207940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of beta-substituted naphth-1-yl ethylamido derivatives as new melatoninergic agonists.
    Mathé-Allainmat M; Le Gall M; Jellimann C; Andrieux J; Langlois M
    Bioorg Med Chem; 1999 Dec; 7(12):2945-52. PubMed ID: 10658600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.
    Teh MT; Sugden D
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):522-8. PubMed ID: 9840420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
    Sun LQ; Chen J; Bruce M; Deskus JA; Epperson JR; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3799-802. PubMed ID: 15203165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of melatonin receptors agonists and antagonists.
    Tarzia G; Diamantini G; Mor M; Spadoni G
    Farmaco; 2000 Mar; 55(3):184-7. PubMed ID: 10919077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.
    Faust R; Garratt PJ; Trujillo Pérez MA; Piccio VJ; Madsen C; Stenstrøm A; Frølund B; Davidson K; Teh MT; Sugden D
    Bioorg Med Chem; 2007 Jul; 15(13):4543-51. PubMed ID: 17459711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
    Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye AL; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
    J Med Chem; 1996 Aug; 39(16):3089-95. PubMed ID: 8759629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
    Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
    J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.
    Tarzia G; Diamantini G; Di Giacomo B; Spadoni G; Esposti D; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
    J Med Chem; 1997 Jun; 40(13):2003-10. PubMed ID: 9207941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of subtype selective melatonin receptor agonists and antagonists.
    Sugden D; Yeh LK; Teh MT
    Reprod Nutr Dev; 1999; 39(3):335-44. PubMed ID: 10420436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.
    Nonno R; Lucini V; Spadoni G; Pannacci M; Croce A; Esposti D; Balsamini C; Tarzia G; Fraschini F; Stankov BM
    J Pineal Res; 2000 Nov; 29(4):234-40. PubMed ID: 11068946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-affinity relationships of indole-based melatonin analogs.
    Spadoni G; Mor M; Tarzia G
    Biol Signals Recept; 1999; 8(1-2):15-23. PubMed ID: 10085458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.